open access
The effect of weight loss on serum concentrations of FAS and tumour necrosis factor alpha in obese women
open access
Abstract
Material and methods: The study group consisted of 23 obese women without additional disease aged 36.6 ± 10.9 years. These were examined before and after three-month weight reduction treatment consisting of a diet of 1000 kcal/day and physical exercise. The control group comprised 17 lean healthy women aged 40.3 ± 5.5 years. Blood samples were taken in the morning after an overnight fast. Serum concentrations of TNF-α, sTNFRs and FAS were measured by enzyme linked immunosorbent assay (ELISA). Serum concentrations of insulin were measured by RIA. Serum concentrations of glucose, total cholesterol, HDL cholesterol and triglycerides were measured by an enzymatic procedure.
Results: The mean weight loss over the three-month treatment was 11.4 ± 3.1 kg. Following weight loss, serum TNF-α concentrations decreased significantly (7.3 ± 3.0 vs. 5.4 ± 1.6 pg/ml; p < 0.005) and concentrations of sTNFRs increased significantly (1222.6 ± 211.8 vs. 1325.6 ± 261.6 pg/ml; p < 0.05 and 1881.5 ± 337.2 vs. 2057.4 ± 358.7 pg/ml; p < 0.05 respectively). However, no changes in serum concentrations of FAS were observed after weight loss.
Conclusion: We observed increased serum concentrations of TNF-α but not of FAS in obese women. The concentrations of TNF decreased and those of sTNFRs increased after weight loss. However, the weight reduction therapy did not change serum concentrations of FAS. Pol J Endocrinol 2008; 59 (1): 18-22
Abstract
Material and methods: The study group consisted of 23 obese women without additional disease aged 36.6 ± 10.9 years. These were examined before and after three-month weight reduction treatment consisting of a diet of 1000 kcal/day and physical exercise. The control group comprised 17 lean healthy women aged 40.3 ± 5.5 years. Blood samples were taken in the morning after an overnight fast. Serum concentrations of TNF-α, sTNFRs and FAS were measured by enzyme linked immunosorbent assay (ELISA). Serum concentrations of insulin were measured by RIA. Serum concentrations of glucose, total cholesterol, HDL cholesterol and triglycerides were measured by an enzymatic procedure.
Results: The mean weight loss over the three-month treatment was 11.4 ± 3.1 kg. Following weight loss, serum TNF-α concentrations decreased significantly (7.3 ± 3.0 vs. 5.4 ± 1.6 pg/ml; p < 0.005) and concentrations of sTNFRs increased significantly (1222.6 ± 211.8 vs. 1325.6 ± 261.6 pg/ml; p < 0.05 and 1881.5 ± 337.2 vs. 2057.4 ± 358.7 pg/ml; p < 0.05 respectively). However, no changes in serum concentrations of FAS were observed after weight loss.
Conclusion: We observed increased serum concentrations of TNF-α but not of FAS in obese women. The concentrations of TNF decreased and those of sTNFRs increased after weight loss. However, the weight reduction therapy did not change serum concentrations of FAS. Pol J Endocrinol 2008; 59 (1): 18-22
Keywords
obesity; FAS; TNFα; sTNFRs


Title
The effect of weight loss on serum concentrations of FAS and tumour necrosis factor alpha in obese women
Journal
Issue
Article type
Original paper
Pages
18-22
Published online
2008-01-21
Page views
605
Article views/downloads
1063
Bibliographic record
Endokrynol Pol 2008;59(1):18-22.
Keywords
obesity
FAS
TNFα
sTNFRs
Authors
Barbara Zahorska-Markiewicz
Magdalena Olszanecka-Glinianowicz
Joanna Janowska
Piotr Kocełak